{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:34:28Z","timestamp":1793226868403,"version":"4.5.0"},"reference-count":84,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000928","name":"Welch Foundation","doi-asserted-by":"publisher","award":["F-0003-19620604"],"award-info":[{"award-number":["F-0003-19620604"]}],"id":[{"id":"10.13039\/100000928","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Immunology"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.coi.2022.102209","type":"journal-article","created":{"date-parts":[[2022,5,19]],"date-time":"2022-05-19T17:19:08Z","timestamp":1652980748000},"page":"102209","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"special_numbering":"C","title":["Principles and practical applications of structure-based vaccine design"],"prefix":"10.1016","volume":"77","author":[{"given":"Patrick O","family":"Byrne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason S","family":"McLellan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coi.2022.102209_bib1","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.chom.2020.04.022","article-title":"Rational vaccine design in the time of COVID-19","volume":"27","author":"Burton","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.coi.2022.102209_bib2","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.coi.2020.03.013","article-title":"Innovations in structure-based antigen design and immune monitoring for next generation vaccines","volume":"65","author":"Ward","year":"2020","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.coi.2022.102209_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.00442","article-title":"Better epitope discovery, precision immune engineering, and accelerated vaccine design using immunoinformatics tools","volume":"11","author":"De Groot","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.coi.2022.102209_bib4","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.coi.2019.03.005","article-title":"Immunological goals for respiratory syncytial virus vaccine development","volume":"59","author":"Graham","year":"2019","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.coi.2022.102209_bib5","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.coi.2020.01.006","article-title":"DNA vaccines: prime time is now","volume":"65","author":"Gary","year":"2020","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.coi.2022.102209_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coi.2020.01.007","article-title":"Shaping humoral immunity to vaccines through antigen-displaying nanoparticles","volume":"65","author":"Irvine","year":"2020","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.coi.2022.102209_bib7","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.coi.2020.01.008","article-title":"Recent advances in mRNA vaccine technology","volume":"65","author":"Pardi","year":"2020","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.coi.2022.102209_bib8","article-title":"Improving AlphaFold modeling using implicit information from experimental density maps","author":"Terwilliger","year":"2022","journal-title":"bioRxiv"},{"key":"10.1016\/j.coi.2022.102209_bib9","doi-asserted-by":"crossref","DOI":"10.1126\/science.abm4805","article-title":"Computed structures of core eukaryotic protein complexes","volume":"374","author":"Humphreys","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.coi.2022.102209_bib10","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.coi.2022.102209_bib11","doi-asserted-by":"crossref","first-page":"7133","DOI":"10.1021\/bi00483a001","article-title":"Dominant forces in protein folding","volume":"29","author":"Dill","year":"1990","journal-title":"Biochemistry"},{"key":"10.1016\/j.coi.2022.102209_bib12","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0065-3233(08)60520-3","article-title":"The anatomy and taxonomy of protein structure","volume":"34","author":"Richardson","year":"1981","journal-title":"Adv Protein Chem"},{"key":"10.1016\/j.coi.2022.102209_bib13","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1126\/science.181.4096.223","article-title":"Principles that govern the folding of protein chains","volume":"181","author":"Anfinsen","year":"1973","journal-title":"Science"},{"key":"10.1016\/j.coi.2022.102209_bib14","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/S0021-9258(18)64177-8","article-title":"Studies on the reduction and re-formation of protein disulfide bonds","volume":"236","author":"Anfinsen","year":"1961","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coi.2022.102209_bib15","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1073\/pnas.47.9.1309","article-title":"The kinetics of formation of native ribonuclease during oxidation of the reduced polypeptide chain","volume":"47","author":"Anfinsen","year":"1961","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.coi.2022.102209_bib16","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1126\/science.125.3250.691","article-title":"Reductive cleavage of disulfide bridges in ribonuclease","volume":"125","author":"Sela","year":"1957","journal-title":"Science"},{"key":"10.1016\/j.coi.2022.102209_bib17","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/prot.340200403","article-title":"Intrinsic secondary structure propensities of the amino acids, using statistical phi-psi matrices: comparison with experimental scales","volume":"20","author":"Munoz","year":"1994","journal-title":"Proteins"},{"key":"10.1016\/j.coi.2022.102209_bib18","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0968-0004(96)10052-9","article-title":"Coiled coils: new structures and new functions","volume":"21","author":"Lupas","year":"1996","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.coi.2022.102209_bib19","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1126\/science.252.5009.1162","article-title":"Predicting coiled coils from protein sequences","volume":"252","author":"Lupas","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.coi.2022.102209_bib20","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1126\/science.2237415","article-title":"A thermodynamic scale for the helix-forming tendencies of the commonly occurring amino acids","volume":"250","author":"O'Neil","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.coi.2022.102209_bib21","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1083\/jcb.141.6.1335","article-title":"Specific single or double proline substitutions in the \"spring-loaded\" coiled-coil region of the influenza hemagglutinin impair or abolish membrane fusion activity","volume":"141","author":"Qiao","year":"1998","journal-title":"J Cell Biol"},{"key":"10.1016\/j.coi.2022.102209_bib22","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1126\/science.1243283","article-title":"Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virus","volume":"342","author":"McLellan","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.coi.2022.102209_bib23","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1126\/science.1234914","article-title":"Structure of RSV fusion glycoprotein trimer bound to a prefusion-specific neutralizing antibody","volume":"340","author":"McLellan","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.coi.2022.102209_bib24","doi-asserted-by":"crossref","first-page":"7417","DOI":"10.1128\/JVI.00808-15","article-title":"Design and structure of an engineered disulfide-stabilized influenza virus hemagglutinin trimer","volume":"89","author":"Lee","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.coi.2022.102209_bib25","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1128\/JVI.74.2.627-643.2000","article-title":"A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure","volume":"74","author":"Binley","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/j.coi.2022.102209_bib26","doi-asserted-by":"crossref","first-page":"5091","DOI":"10.1128\/JVI.74.11.5091-5100.2000","article-title":"Variable-loop-deleted variants of the human immunodeficiency virus type 1 envelope glycoprotein can be stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits","volume":"74","author":"Sanders","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/j.coi.2022.102209_bib27","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1126\/science.1553543","article-title":"Response of a protein structure to cavity-creating mutations and its relation to the hydrophobic effect","volume":"255","author":"Eriksson","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.coi.2022.102209_bib28","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0022-2836(02)00465-5","article-title":"Thermodynamic consequences of burial of polar and non-polar amino acid residues in the protein interior","volume":"320","author":"Loladze","year":"2002","journal-title":"J Mol Biol"},{"key":"10.1016\/j.coi.2022.102209_bib29","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1002\/prot.24231","article-title":"Structural, energetic, and dynamic responses of the native state ensemble of staphylococcal nuclease to cavity-creating mutations","volume":"81","author":"Roche","year":"2013","journal-title":"Proteins"},{"key":"10.1016\/j.coi.2022.102209_bib30","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/0022-2836(92)90562-X","article-title":"Fersht AR: the folding of an enzyme. II. Substructure of barnase and the contribution of different interactions to protein stability","volume":"224","author":"Serrano","year":"1992","journal-title":"J Mol Biol"},{"key":"10.1016\/j.coi.2022.102209_bib31","doi-asserted-by":"crossref","first-page":"8033","DOI":"10.1021\/bi00487a007","article-title":"Contributions of the large hydrophobic amino acids to the stability of staphylococcal nuclease","volume":"29","author":"Shortle","year":"1990","journal-title":"Biochemistry"},{"key":"10.1016\/j.coi.2022.102209_bib32","doi-asserted-by":"crossref","first-page":"9888","DOI":"10.1128\/JVI.76.19.9888-9899.2002","article-title":"Mutagenic stabilization and\/or disruption of a CD4-bound state reveals distinct conformations of the human immunodeficiency virus type 1 gp120 envelope glycoprotein","volume":"76","author":"Xiang","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.coi.2022.102209_bib33","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms9143","article-title":"A highly stable prefusion RSV F vaccine derived from structural analysis of the fusion mechanism","volume":"6","author":"Krarup","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.coi.2022.102209_sbref34","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.celrep.2018.03.061","article-title":"A universal approach to optimize the folding and stability of prefusion-closed HIV-1 envelope trimers","volume":"23","author":"Rutten","year":"2018","journal-title":"Cell Rep"},{"key":"10.1016\/j.coi.2022.102209_bib35","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.chom.2019.04.003","article-title":"Influenza antigen engineering focuses immune responses to a subdominant but broadly protective viral epitope","volume":"25","author":"Bajic","year":"2019","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.coi.2022.102209_bib36","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/s41591-021-01660-8","article-title":"Safety and immunogenicity of a ferritin nanoparticle H2 influenza vaccine in healthy adults: a phase 1 trial","volume":"28","author":"Houser","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.coi.2022.102209_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009897","article-title":"Novel virus-like nanoparticle vaccine effectively protects animal model from SARS-CoV-2 infection","volume":"17","author":"Geng","year":"2021","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coi.2022.102209_bib38","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.cell.2019.01.046","article-title":"Induction of potent neutralizing antibody responses by a designed protein nanoparticle vaccine for respiratory syncytial virus","volume":"176","author":"Marcandalli","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.coi.2022.102209_bib39","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-03146-7","article-title":"Structure-based design of chimeric antigens for multivalent protein vaccines","volume":"9","author":"Hollingshead","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.coi.2022.102209_bib40","doi-asserted-by":"crossref","DOI":"10.1002\/jia2.25797","article-title":"Structure-guided envelope trimer design in HIV-1 vaccine development: a narrative review","volume":"24","author":"Derking","year":"2021","journal-title":"J Int AIDS Soc"},{"key":"10.1016\/j.coi.2022.102209_bib41","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.coviro.2021.09.015","article-title":"Strategies for eliciting multiple lineages of broadly neutralizing antibodies to HIV by vaccination","volume":"51","author":"Mu","year":"2021","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.coi.2022.102209_bib42","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.coi.2021.07.003","article-title":"COVID-19 vaccines","volume":"71","author":"Ndwandwe","year":"2021","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.coi.2022.102209_bib43","unstructured":"World Health Organization: COVID-19 Vaccine Tracker and Landscape. \u3008https:\/\/www.who.int\/publications\/m\/item\/draft-landscape-of-covid-19-candidate-vaccines\u3009."},{"key":"10.1016\/j.coi.2022.102209_bib44","doi-asserted-by":"crossref","first-page":"E7348","DOI":"10.1073\/pnas.1707304114","article-title":"Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen","volume":"114","author":"Pallesen","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.coi.2022.102209_bib45","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.abb2507","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","volume":"367","author":"Wrapp","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.coi.2022.102209_bib46","doi-asserted-by":"crossref","first-page":"11157","DOI":"10.1073\/pnas.1708727114","article-title":"Tectonic conformational changes of a coronavirus spike glycoprotein promote membrane fusion","volume":"114","author":"Walls","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.coi.2022.102209_bib47","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1126\/science.abd4251","article-title":"Distinct conformational states of SARS-CoV-2 spike protein","volume":"369","author":"Cai","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.coi.2022.102209_bib48","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1021\/acscentsci.1c00080","article-title":"Native-like SARS-CoV-2 spike glycoprotein expressed by ChAdOx1 nCoV-19\/AZD1222 vaccine","volume":"7","author":"Watanabe","year":"2021","journal-title":"ACS Cent Sci"},{"key":"10.1016\/j.coi.2022.102209_sbref48","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/s41594-020-0479-4","article-title":"Controlling the SARS-CoV-2 spike glycoprotein conformation","volume":"27","author":"Henderson","year":"2020","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.coi.2022.102209_sbref49","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1126\/science.abd0826","article-title":"Structure-based design of prefusion-stabilized SARS-CoV-2 spikes","volume":"369","author":"Hsieh","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.coi.2022.102209_sbref50","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-20321-x","article-title":"Stabilizing the closed SARS-CoV-2 spike trimer","volume":"12","author":"Juraszek","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.coi.2022.102209_bib52","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/s41594-020-0483-8","article-title":"Structure-guided covalent stabilization of coronavirus spike glycoprotein trimers in the closed conformation","volume":"27","author":"McCallum","year":"2020","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.coi.2022.102209_bib53","article-title":"Structure-based design of a highly stable, covalently-linked SARS-CoV-2 spike trimer with improved structural properties and immunogenicity","author":"Olmedillas","year":"2021","journal-title":"bioRxiv"},{"key":"10.1016\/j.coi.2022.102209_bib54","doi-asserted-by":"crossref","first-page":"5339","DOI":"10.1038\/s41596-021-00623-0","article-title":"Expression and characterization of SARS-CoV-2 spike proteins","volume":"16","author":"Schaub","year":"2021","journal-title":"Nat Protoc"},{"key":"10.1016\/j.coi.2022.102209_bib55","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/s41594-020-0478-5","article-title":"A thermostable, closed SARS-CoV-2 spike protein trimer","volume":"27","author":"Xiong","year":"2020","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.coi.2022.102209_bib56","article-title":"Glycans on the SARS-CoV-2 spike control the receptor binding domain conformation","author":"Henderson","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.coi.2022.102209_sbref56","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.cell.2020.08.012","article-title":"Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding","volume":"182","author":"Starr","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.coi.2022.102209_bib58","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1038\/s41564-021-00954-4","article-title":"SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution","volume":"6","author":"Zahradnik","year":"2021","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.coi.2022.102209_bib59","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1126\/science.abd3255","article-title":"Free fatty acid binding pocket in the locked structure of SARS-CoV-2 spike protein","volume":"370","author":"Toelzer","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.coi.2022.102209_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109929","article-title":"Stabilized coronavirus spike stem elicits a broadly protective antibody","volume":"37","author":"Hsieh","year":"2021","journal-title":"Cell Rep"},{"key":"10.1016\/j.coi.2022.102209_bib61","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1126\/science.abi4506","article-title":"Chimeric spike mRNA vaccines protect against Sarbecovirus challenge in mice","volume":"373","author":"Martinez","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.coi.2022.102209_bib62","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S1473-3099(19)30393-7","article-title":"Immunogenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomised, placebo-controlled, phase 1 clinical trial","volume":"20","author":"Bernstein","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.coi.2022.102209_sbref62","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/s41591-020-1118-7","article-title":"A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial","volume":"27","author":"Nachbagauer","year":"2021","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.coi.2022.102209_sbref63","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1016\/j.ymthe.2022.01.011","article-title":"A single-shot adenoviral vaccine provides hemagglutinin stalk-mediated protection against heterosubtypic influenza challenge in mice","volume":"30","author":"Bliss","year":"2022","journal-title":"Mol Ther"},{"key":"10.1016\/j.coi.2022.102209_bib65","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/s41586-021-04356-8","article-title":"Broadly neutralizing antibodies target a hemagglutinin anchor epitope","volume":"602","author":"Guthmiller","year":"2022","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.coi.2022.102209_bib66","doi-asserted-by":"crossref","first-page":"666","DOI":"10.3390\/vaccines8040666","article-title":"Development and assessment of a pooled serum as candidate standard to measure influenza A virus Group 1 hemagglutinin stalk-reactive antibodies","volume":"8","author":"Carreno","year":"2020","journal-title":"Vaccines (Basel)"},{"issue":"583","key":"10.1016\/j.coi.2022.102209_sbref66","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abe5449","article-title":"Broad neutralization of H1 and H3 viruses by adjuvanted influenza HA stem vaccines in nonhuman primates","volume":"13","author":"Darricarrere","year":"2021","journal-title":"Sci Transl Med"},{"issue":"1","key":"10.1016\/j.coi.2022.102209_bib68","doi-asserted-by":"crossref","first-page":"e02810","DOI":"10.1128\/mBio.02810-18","article-title":"Design of nanoparticulate Group 2 influenza virus hemagglutinin stem antigens that activate unmutated ancestor B cell receptors of broadly neutralizing antibody lineages","volume":"10","author":"Corbett","year":"2019","journal-title":"mBio"},{"key":"10.1016\/j.coi.2022.102209_bib69","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/nm.3927","article-title":"Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection","volume":"21","author":"Yassine","year":"2015","journal-title":"Nat Med"},{"issue":"10","key":"10.1016\/j.coi.2022.102209_bib70","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.3390\/v13101942","article-title":"Combinatorial F-G immunogens as Nipah and respiratory syncytial virus vaccine candidates","volume":"13","author":"Isaacs","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.coi.2022.102209_sbref70","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.772864","article-title":"Chimeric Fusion (F) and Attachment (G) glycoprotein antigen delivery by mRNA as a candidate Nipah vaccine","volume":"12","author":"Loomis","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.coi.2022.102209_bib72","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.00842","article-title":"Structure-based design of Nipah virus vaccines: a generalizable approach to Paramyxovirus immunogen development","volume":"11","author":"Loomis","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.coi.2022.102209_bib73","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1038\/s41594-019-0308-9","article-title":"An antibody against the F glycoprotein inhibits Nipah and Hendra virus infections","volume":"26","author":"Dang","year":"2019","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.coi.2022.102209_bib74","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/s41594-021-00584-8","article-title":"Broadly neutralizing antibody cocktails targeting Nipah virus and Hendra virus fusion glycoproteins","volume":"28","author":"Dang","year":"2021","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.coi.2022.102209_bib75","doi-asserted-by":"crossref","first-page":"12265","DOI":"10.1073\/pnas.1811980115","article-title":"Structure-based design of a quadrivalent fusion glycoprotein vaccine for human parainfluenza virus types 1-4","volume":"115","author":"Stewart-Jones","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.coi.2022.102209_bib76","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-28931-3","article-title":"Structure-based design of prefusion-stabilized human metapneumovirus fusion proteins","volume":"13","author":"Hsieh","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.coi.2022.102209_bib77","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-09807-5","article-title":"Transient opening of trimeric prefusion RSV F proteins","volume":"10","author":"Gilman","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.coi.2022.102209_bib78","doi-asserted-by":"crossref","first-page":"4540","DOI":"10.1016\/j.celrep.2020.03.025","article-title":"Structure-based design of prefusion-stabilized filovirus glycoprotein trimers","volume":"30","author":"Rutten","year":"2020","journal-title":"Cell Rep"},{"issue":"4","key":"10.1016\/j.coi.2022.102209_bib79","doi-asserted-by":"crossref","first-page":"e01408","DOI":"10.1128\/mBio.01408-19","article-title":"A Hyperstabilizing Mutation in the base of the Ebola virus glycoprotein acts at multiple steps to abrogate viral entry","volume":"10","author":"Fels","year":"2019","journal-title":"mBio"},{"key":"10.1016\/j.coi.2022.102209_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2021.166964","article-title":"Community-wide experimental evaluation of the PROSS stability-design method","volume":"433","author":"Peleg","year":"2021","journal-title":"J Mol Biol"},{"key":"10.1016\/j.coi.2022.102209_bib81","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1073\/pnas.1616903114","article-title":"One-step design of a stable variant of the malaria invasion protein RH5 for use as a vaccine immunogen","volume":"114","author":"Campeotto","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.coi.2022.102209_bib82","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.molcel.2016.06.012","article-title":"Automated structure- and sequence-based design of proteins for high bacterial expression and stability","volume":"63","author":"Goldenzweig","year":"2016","journal-title":"Mol Cell"},{"key":"10.1016\/j.coi.2022.102209_bib83","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1021\/acssynbio.0c00345","article-title":"Discovery of novel gain-of-function mutations guided by structure-based deep learning","volume":"9","author":"Shroff","year":"2020","journal-title":"ACS Synth Biol"},{"key":"10.1016\/j.coi.2022.102209_bib84","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nature13001","article-title":"The ensemble nature of allostery","volume":"508","author":"Motlagh","year":"2014","journal-title":"Nature"}],"container-title":["Current Opinion in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791522000565?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791522000565?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T08:47:15Z","timestamp":1760604435000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952791522000565"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":84,"alternative-id":["S0952791522000565"],"URL":"https:\/\/doi.org\/10.1016\/j.coi.2022.102209","relation":{},"ISSN":["0952-7915"],"issn-type":[{"value":"0952-7915","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Principles and practical applications of structure-based vaccine design","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coi.2022.102209","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102209"}}